Categories: Reuters

Bausch Health’s lotion for plaque psoriasis wins FDA approval

By Aakash B

(Reuters) – The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc’s topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

Duobrii, which is priced at $825 for a 100-gram tube, is 50 percent lower than other branded topical treatments, the company said. It is expected to be available in the United States in June.

U.S.-listed shares of the company, formerly known as Valeant Pharmaceuticals, rose 3.5 percent to $23.82.

In June, the FDA had declined to approve Duobrii, seeking details on its pharmacokinetic data, which shows how the body reacts to a treatment, including the duration and intensity of the drug’s effects.

Since taking over from former Chief Executive Officer Michael Pearson in 2016, when erstwhile Valeant was hit by a flurry of investigations into its accounting and pricing practices, CEO Joseph Papa has worked to regain investor confidence and has been building on the company’s product portfolio.

The treatment is part of Bausch’s “Significant Seven”, a suite of seven key products expected to generate more than $1 billion in sales over the next five years.

Market for global psoriasis drugs is expected to touch $21.11 billion by 2022, according to U.S. consultant Grand View Research.

Psoriasis is a chronic condition that causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which can be itchy and painful. As many as 7.5 million Americans suffer from plaque psoriasis disease.

The green signal from FDA for Duobrii comes after a similar plaque psoriasis lotion, Bryhali, was granted a tentative approval by the health regulator in October.

(Reporting by Manojna Maddipatla and Aakash Jagadeesh Babu in Bengaluru; Editing by James Emmanuel)

Reuters

Recent Posts

  • Reuters

Missouri follows Alabama by passing restrictive abortion bill

(Reuters) - Missouri lawmakers passed a bill on Friday that prohibits women from seeking an abortion after the eighth week…

1 day ago
  • Reuters

Too much screen time tied to school problems even in little kids

By Lisa Rapaport (Reuters Health) - Kindergarteners who get more than two hours of screen time a day may be…

1 day ago
  • Reuters

Smokers have higher risk for multiple strokes

By Lisa Rapaport (Reuters Health) - Smokers who have a stroke are much more likely to have another one if…

2 days ago
  • Reuters

U.S. FDA labels J&J surgical staplers’ recall as severest

(Reuters) - The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made…

2 days ago
  • Reuters

Sunday is ‘Hepatitis Testing Day’

By Carolyn Crist Millions of people in the U.S. have chronic viral hepatitis, most without knowing it, so the Centers…

2 days ago
  • Reuters

More U.S. mothers diagnosed with depression at childbirth

By Lisa Rapaport Growing numbers of new mothers are being diagnosed with depression before they leave the hospital with their…

2 days ago